Literature DB >> 10686466

Type I sialidosis: a clinical, biochemical and neuroradiological study.

S Palmeri1, M Villanova, A Malandrini, O P van Diggelen, J G Huijmans, C Ceuterick, A Rufa, D DeFalco, G Ciacci, J J Martin, G Guazzi.   

Abstract

We report biochemical, morphological and neuroradiological findings in a 40-year-old woman affected with type I sialidosis. The clinical symptoms, consisting of a cerebellar syndrome, were first noted at the age of 17 years. The macular cherry-red spot was first observed after 23 years of disease. A CT scan performed at 21 years of age showed enlargement of the fourth ventricle. Nuclear magnetic resonance imaging of the brain performed at the age of 40 showed severe atrophy of the cerebellum and pontine region; atrophy of cerebral hemispheres and of the corpus callosum was also observed. We emphasize the prolonged course of illness in this patient, observed over a long period of time. Of particular interest is the neuroradiological study showing our findings both at the beginning of the disease and after 20 years. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2000        PMID: 10686466     DOI: 10.1159/000008141

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  10 in total

Review 1.  Young onset dementia.

Authors:  E L Sampson; J D Warren; M N Rossor
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

Review 2.  Progressive myoclonic epilepsies: review of clinical, molecular and therapeutic aspects.

Authors:  Luis Felipe Mendonça de Siqueira
Journal:  J Neurol       Date:  2010-07-01       Impact factor: 4.849

Review 3.  NEU1-A Unique Therapeutic Target for Alzheimer's Disease.

Authors:  Aiza Khan; Consolato M Sergi
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

Review 4.  Radiological and clinical characterization of the lysosomal storage disorders: non-lipid disorders.

Authors:  E I Parker; M Xing; A Moreno-De-Luca; E Harmouche; M R Terk
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

5.  Genetic and clinical characterization of mainland Chinese patients with sialidosis type 1.

Authors:  Xiaoxu Han; Shijing Wu; Min Wang; Hui Li; Yan Huang; Ruifang Sui
Journal:  Mol Genet Genomic Med       Date:  2020-05-26       Impact factor: 2.183

6.  Compound heterozygous mutations in the neuraminidase 1 gene in type 1 sialidosis: A case report and review of literature.

Authors:  Lan-Xiao Cao; Ying Liu; Zhao-Jun Song; Bao-Rong Zhang; Wen-Ying Long; Guo-Hua Zhao
Journal:  World J Clin Cases       Date:  2021-01-26       Impact factor: 1.337

7.  Hematopoietic cell transplantation for sialidosis type I.

Authors:  Ashish O Gupta; Marc C Patterson; Tim Wood; Julie B Eisengart; Paul J Orchard; Troy C Lund
Journal:  Mol Genet Metab Rep       Date:  2021-12-08

8.  Fundus autofluorescence and optical coherence tomography of a macular cherry-red spot in a case report of sialidosis.

Authors:  Wenjun Zou; Xin Wang; Guohong Tian
Journal:  BMC Ophthalmol       Date:  2016-03-22       Impact factor: 2.209

Review 9.  Sialidosis: A Review of Morphology and Molecular Biology of a Rare Pediatric Disorder.

Authors:  Aiza Khan; Consolato Sergi
Journal:  Diagnostics (Basel)       Date:  2018-04-25

10.  Sialidosis Type I without a Cherry Red Spot- Is There a Genetic Basis?

Authors:  Koti Neeraja; Vikram Venkappayya Holla; Shweta Prasad; Bharath Kumar Surisetti; Kempaiah Rakesh; Nitish Kamble; Ravi Yadav; Pramod Kumar Pal
Journal:  J Mov Disord       Date:  2020-10-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.